articleAnnals of the Rheumatic DiseasesFeb 9, 2015Closed access

Rituximab for IgG4-related disease: a prospective, open-label trial

MNMollie N. CarruthersMTMark TopazianAKArezou KhosroshahiTEThomas E. WitzigZSZachary S. Wallace

Harvard University · Massachusetts General Hospital · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

695
total citations
FWCI
54.38
Percentile
100%
References
27
Citations per year

Authors

10

Topics & keywords

Topics
Keywords
  • Medicine
  • Rituximab
  • IgG4-related disease
  • Internal medicine
  • Gastroenterology
  • Open label
  • Clinical trial
  • Surgery
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.